NorthWest Biotherapeutics Inc (NWBO)

[gnawkz]

Complicated by the fact that the initial disclosure by NWBO occurred in the June '14 10Q filed Aug! meaning because NWBO is so understaffed and LP apparently does quadruple type duties the 10Q is her catch all instead of a press release.

This point has always been a large risk factor for me.

As a Biotech company transitions from a focus on the Science / Clinical Trials to a full company that has to send invoices, pay vendors, collect sales, and all other operational steps, how does it expand fast enough to perform all of these actions?

I know past companies have been able to do it, but does anyone on this board have knowledge of the level of difficulty, time, and cost of growing internal operations to meet the needs of the market?